N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide

C31H47NO6 — CID 58359174

IUPACN-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide
SMILESCC(=O)CCC(=O)C[C@@H](CCCC1CCCCC1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)CCC(=O)CO
InChIInChI=1S/C31H47NO6/c1-23(34)15-16-27(35)19-26(14-8-13-24-9-4-2-5-10-24)21-30(37)29(20-25-11-6-3-7-12-25)32-31(38)18-17-28(36)22-33/h3,6-7,11-12,24,26,29-30,33,37H,2,4-5,8-10,13-22H2,1H3,(H,32,38)/t26-,29+,30+/m1/s1
InChIKeyPIURGPLTBZDDOY-POLDFPFKSA-N
MW529.72 g/mol
LogP4.50
Rot. Bonds19

About N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide

N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide (PubChem CID 58359174) has the molecular formula C31H47NO6 and a molecular weight of 529.72 g/mol. Its IUPAC name is N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide.

Molecular Properties

Compound NameN-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide
PubChem CID58359174
Molecular FormulaC31H47NO6
Molecular Weight529.72 g/mol
Exact Mass529.34
IUPAC NameN-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide
SMILESCC(=O)CCC(=O)C[C@@H](CCCC1CCCCC1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)CCC(=O)CO
InChIInChI=1S/C31H47NO6/c1-23(34)15-16-27(35)19-26(14-8-13-24-9-4-2-5-10-24)21-30(37)29(20-25-11-6-3-7-12-25)32-31(38)18-17-28(36)22-33/h3,6-7,11-12,24,26,29-30,33,37H,2,4-5,8-10,13-22H2,1H3,(H,32,38)/t26-,29+,30+/m1/s1
InChIKeyPIURGPLTBZDDOY-POLDFPFKSA-N
XLogP4.50
TPSA120.77 Ų
H-Bond Donors3
H-Bond Acceptors6
Rotatable Bonds19
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500529.72
LogP ≤ 54.50
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 106

Analyze N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide?
The IUPAC name of N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide (CID 58359174) is N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide.
What is the SMILES notation for N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide?
The canonical SMILES for N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide is CC(=O)CCC(=O)C[C@@H](CCCC1CCCCC1)C[C@H](O)[C@H](Cc1ccccc1)NC(=O)CCC(=O)CO.
What is the InChIKey of N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide?
The InChIKey is PIURGPLTBZDDOY-POLDFPFKSA-N. The full InChI is InChI=1S/C31H47NO6/c1-23(34)15-16-27(35)19-26(14-8-13-24-9-4-2-5-10-24)21-30(37)29(20-25-11-6-3-7-12-25)32-31(38)18-17-28(36)22-33/h3,6-7,11-12,24,26,29-30,33,37H,2,4-5,8-10,13-22H2,1H3,(H,32,38)/t26-,29+,30+/m1/s1.
What are the key properties of N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide?
N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide has a molecular weight of 529.72 g/mol, XLogP of 4.50, 19 rotatable bonds, 3 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S,3S,5S)-5-(3-cyclohexylpropyl)-3-hydroxy-7,10-dioxo-1-phenylundecan-2-yl]-5-hydroxy-4-oxopentanamide is sourced from PubChem (CID 58359174), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).